Convexia
San Francisco
About Convexia
Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Sep 2025)
- Website: convexia.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Information Technology, Machine Learning, Real Time
Social Profiles
Canonical: https://fsome.com/organization/convexia-28394 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.